MarketPeel
Insider Trading Intelligence
Pricing
…
AG

Ansbert Gadicke

CGEM
DIRECTOR · CULLINAN THERAPEUTICS, INC. · CIK 0001134655
FILING MIX · LIFETIME24%/76%
BUYS
28
SELLS
88
TOTAL VALUE
$44.25M
COMPANIES
5
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
9,181,648
AVG SELL PX
$5.25
TRADE KIND
SHOWING 116 / 116
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
70 backtested trades · 8 horizons · 62 pending
Forward-return performance of every backtestable P/S trade by Ansbert Gadicke, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d70+67.14%-5.72%-0.48%-5.24%-5.35%-4.35
14d70+68.57%-9.28%-0.71%-8.57%-8.75%-5.00
30d70+91.43%-18.11%-0.75%-17.36%-16.68%-11.48
60d70+97.14%-28.18%+2.49%-30.67%-28.73%-14.45
90d70+97.14%-36.80%+2.74%-39.54%-41.88%-28.52
180d70(1 pending)+95.65%-46.51%+1.11%-46.82%-48.87%-24.99
1y70(29 pending)+95.12%-53.27%-6.56%-46.71%-44.04%-37.20
2y70(32 pending)+94.74%-63.97%+2.60%-66.57%-66.13%-107.70
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CGEM · 16,475 shares · as of Jun 22, 2022
01,978,4723,956,9445,935,4157,913,8872022SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 28 buys / 88 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AKTS
AKTIS ONCOLOGY, INC.
SALE
22,500,000——0Jan 12, 2026Jan 14, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,112,777$18.00$20.03M10,260,064Jan 12, 2026Jan 14, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,577,119——9,147,287Jan 12, 2026Jan 14, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
5,914,197——7,570,168Jan 12, 2026Jan 14, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,314,262——1,655,971Jan 12, 2026Jan 14, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
5,000,000——0Jan 12, 2026Jan 14, 2026 ↗View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
6,000,000——0Jan 12, 2026Jan 14, 2026 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
83,230$0.97$80.7K4,784,111Dec 4, 2025Dec 4, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
57,225$0.87$49.8K4,867,341Dec 3, 2025Dec 4, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
59,277$0.89$52.8K4,924,566Dec 2, 2025Dec 4, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
60,917$0.94$57.3K4,983,843Dec 1, 2025Dec 1, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,277$0.99$20.1K5,044,760Nov 28, 2025Dec 1, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
60,733$0.98$59.5K5,065,037Nov 26, 2025Dec 1, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
42,533$0.92$39.1K5,125,770Nov 25, 2025Nov 25, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
88,802$0.98$87.0K5,168,303Nov 24, 2025Nov 25, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
64,331$0.83$53.4K5,257,105Nov 21, 2025Nov 25, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
41,152$0.89$36.6K5,321,436Nov 20, 2025Nov 20, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
66,324$0.94$62.3K5,362,588Nov 19, 2025Nov 20, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
52,627$0.93$48.9K5,428,912Nov 18, 2025Nov 20, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
57,061$0.95$54.2K5,481,539Nov 17, 2025Nov 17, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
61,640$0.93$57.3K5,538,600Nov 14, 2025Nov 17, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
90,951$0.98$89.1K5,600,240Nov 13, 2025Nov 17, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
40,669$1.09$44.3K5,691,191Nov 12, 2025Nov 12, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
55,810$1.14$63.6K5,731,860Nov 11, 2025Nov 12, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
48,570$1.18$57.3K5,787,670Nov 10, 2025Nov 12, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
68,480$1.11$76.0K5,836,240Nov 7, 2025Nov 12, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
54,452$1.21$65.9K5,904,720Nov 6, 2025Nov 6, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
47,950$1.22$58.5K5,959,172Nov 5, 2025Nov 6, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
140,488$1.22$171.4K6,007,122Nov 4, 2025Nov 6, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
94,063$1.29$121.3K6,147,610Nov 3, 2025Nov 3, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
114,044$1.28$146.0K6,241,673Oct 31, 2025Nov 3, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
86,936$1.43$124.3K6,355,717Oct 30, 2025Nov 3, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
134,240$1.55$208.1K6,442,653Oct 29, 2025Oct 29, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
69,068$1.64$113.3K6,576,893Oct 28, 2025Oct 29, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
72,709$1.72$125.1K6,645,961Oct 27, 2025Oct 29, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
50,873$0.09$4.6K6,723,056Mar 27, 2025Apr 30, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
4,386$1.05$4.6K6,718,670Mar 27, 2025Apr 30, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
42,842——0Mar 27, 2025Apr 30, 2025 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
8,031——0Mar 27, 2025Apr 30, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
21,787$20.23$440.8K4,381,062Dec 11, 2024Dec 12, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
22,935$20.77$476.4K4,402,849Dec 10, 2024Dec 12, 2024 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,475——16,475Jun 22, 2022Jun 23, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
27,617,675——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
100,000$20.00$2.00M4,425,784Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
3,683,241——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
3,816,760——3,816,760Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
509,024——4,325,784Nov 2, 2021Nov 4, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,800——7,800Sep 16, 2021Mar 25, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
432$29.06$12.6K244,551Sep 16, 2021Sep 20, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
3,124$29.06$90.8K7,648,268Sep 16, 2021Sep 20, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
6,425$29.16$187.4K7,651,392Sep 15, 2021Sep 16, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
888$29.16$25.9K244,983Sep 15, 2021Sep 16, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
7,106$29.17$207.3K7,657,817Sep 14, 2021Sep 16, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
982$29.17$28.6K245,871Sep 14, 2021Sep 16, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
3,595$29.10$104.6K7,664,923Sep 13, 2021Sep 13, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
497$29.10$14.5K246,853Sep 13, 2021Sep 13, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
5,931$29.04$172.2K7,668,518Sep 10, 2021Sep 13, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
820$29.04$23.8K247,350Sep 10, 2021Sep 13, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
13,727$29.35$402.9K7,674,449Sep 9, 2021Sep 13, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
1,898$29.35$55.7K248,170Sep 9, 2021Sep 13, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
1,499$29.11$43.6K250,068Sep 8, 2021Sep 8, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
10,842$29.11$315.6K7,688,176Sep 8, 2021Sep 8, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
3,465$29.04$100.6K251,567Sep 7, 2021Sep 8, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
25,067$29.04$727.9K7,699,018Sep 7, 2021Sep 8, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
12,731$29.60$376.8K7,724,085Sep 3, 2021Sep 8, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
1,760$29.60$52.1K255,032Sep 3, 2021Sep 8, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
15,757$29.46$464.2K7,736,816Sep 2, 2021Sep 2, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
2,178$29.46$64.2K256,792Sep 2, 2021Sep 2, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
790$29.47$23.3K258,970Sep 1, 2021Sep 2, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
5,714$29.47$168.4K7,752,573Sep 1, 2021Sep 2, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
1,553$30.14$46.8K7,758,287Aug 31, 2021Sep 2, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
215$30.14$6.5K259,760Aug 31, 2021Sep 2, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
1,285$29.43$37.8K7,759,840Aug 31, 2021Sep 2, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
177$29.43$5.2K259,975Aug 31, 2021Sep 2, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
31,001$29.30$908.3K7,761,125Aug 30, 2021Aug 31, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
4,285$29.30$125.6K260,152Aug 30, 2021Aug 31, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
13,357$29.09$388.6K7,792,126Aug 27, 2021Aug 31, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
1,846$29.09$53.7K264,437Aug 27, 2021Aug 31, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
1,713$29.09$49.8K7,805,483Aug 25, 2021Aug 25, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
237$29.09$6.9K266,283Aug 25, 2021Aug 25, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
7,025$29.48$207.1K266,520Aug 24, 2021Aug 25, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
50,882$29.48$1.50M7,807,196Aug 24, 2021Aug 25, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
53,359$29.11$1.55M7,858,018Aug 23, 2021Aug 25, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
7,376$29.11$214.7K273,545Aug 23, 2021Aug 25, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
2,510$29.05$72.9K7,911,377Aug 11, 2021Aug 12, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
347$29.05$10.1K280,921Aug 11, 2021Aug 12, 2021 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
1,488,033——6,427,183May 4, 2021May 6, 2021 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
245,000$16.00$3.92M6,672,183May 4, 2021May 6, 2021 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
4,477,742——4,939,150May 4, 2021May 6, 2021 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
12,899,925——0May 4, 2021May 6, 2021 ↗View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
38,817,998——0May 4, 2021May 6, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
1,136,525——1,136,525Jan 12, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
649,030——7,613,887Jan 12, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
649,030——0Jan 12, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
1,136,525——0Jan 12, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
2,276,692——0Jan 12, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
3,551,640——0Jan 12, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
2,276,692——6,964,857Jan 12, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
300,000$21.00$6.30M7,913,887Jan 12, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
3,551,640——4,688,165Jan 12, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
3,551,640——3,551,640Jan 7, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
1,136,525——1,136,525Jan 7, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
88,824——88,824Jan 7, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
2,276,692——2,276,692Jan 7, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
649,030——649,030Jan 7, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
281,268——281,268Jan 7, 2021Jan 14, 2021 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
262,114——262,114Jan 7, 2021Jan 14, 2021 ↗View →
DYN
DYNE THERAPEUTICS, INC.
SALE
70,492——0Sep 21, 2020Sep 23, 2020 ↗View →
DYN
DYNE THERAPEUTICS, INC.
SALE
1,326,313——0Sep 21, 2020Sep 23, 2020 ↗View →
DYN
DYNE THERAPEUTICS, INC.
SALE
26,176——0Sep 21, 2020Sep 23, 2020 ↗View →
DYN
DYNE THERAPEUTICS, INC.
SALE
275,932——0Sep 21, 2020Sep 23, 2020 ↗View →
DYN
DYNE THERAPEUTICS, INC.
PURCHASE
245,279——245,279Sep 21, 2020Sep 23, 2020 ↗View →
DYN
DYNE THERAPEUTICS, INC.
PURCHASE
91,081——91,081Sep 21, 2020Sep 23, 2020 ↗View →
DYN
DYNE THERAPEUTICS, INC.
PURCHASE
4,614,943——4,614,943Sep 21, 2020Sep 23, 2020 ↗View →
DYN
DYNE THERAPEUTICS, INC.
SALE
743,076——0Sep 21, 2020Sep 23, 2020 ↗View →
DYN
DYNE THERAPEUTICS, INC.
SALE
13,980,992——0Sep 21, 2020Sep 23, 2020 ↗View →
Other insiders · CGEM
Loading peer insiders…
About this filer
CIK 0001134655
ROLE
Director
PRIMARY
CGEM
COMPANIES
5
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001134655DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback